Skip to main content
Top

Open Access 11-03-2024 | Juvenile Rheumatoid Arthritis

Paediatric Rheumatology Fails to Meet Current Benchmarks, a Call for Health Equity for Children Living with Juvenile Idiopathic Arthritis, Using Digital Health Technologies

Authors: Sonia Butler, Dean Sculley, Derek Santos, Xavier Girones, Davinder Singh-Grewal, Andrea Coda

Published in: Current Rheumatology Reports

Login to get access

Abstract

Purpose of Review

This critical review begins by presenting the history of Juvenile Idiopathic Arthritis (JIA) management. To move the conversation forward in addressing the current shortcomings that exist in the clinical management of children living with JIA, we argue that to date, the advancement of successful treatments for JIA has been historically slow. Factors implicated in this situation include a lack of rigorous research, JIA being considered a rare disease, and JIA’s idiopathic and complex pathophysiology.

Recent Findings

Despite the well-intended legislative changes to increase paediatric research, and the major advancements seen in molecular medicine over the last 30 years, globally, paediatric rheumatology services are still failing to meet the current benchmarks of best practice. Provoking questions on how the longstanding health care disparities of poor access and delayed treatment for children living with JIA can be improved, to improve healthcare outcomes.

Summary

Globally, paediatric rheumatology services are failing to meet the current benchmarks of best practice. Raising awareness of the barriers hindering JIA management is the first step in reducing the current health inequalities experienced by children living with JIA. Action must be taken now, to train and well-equip the paediatric rheumatology interdisciplinary workforce. We propose, a resource-efficient way to improve the quality of care provided could be achieved by embedding digital health into clinical practice, to create an integrative care model between the children, general practice and the paediatric rheumatology team. To improve fragmented service delivery and the coordination of interdisciplinary care, across the healthcare system.
Literature
25.
go back to reference Saggese G, Vierucci, F. Systemic corticosteroids for inflammatory disorders in pediatrics. In: C Roland, ed. Systemic corticosteroids for autoimmune/inflammatory disorders in children: introduction. Switzerland: Adis, Springer International Publishing; 2015. Saggese G, Vierucci, F. Systemic corticosteroids for inflammatory disorders in pediatrics. In: C Roland, ed. Systemic corticosteroids for autoimmune/inflammatory disorders in children: introduction. Switzerland: Adis, Springer International Publishing; 2015.
26.
go back to reference Minden K, Kiessling U, Listing J, et al. Prognosis of patients with juvenile chronic arthritis and juvenile spondyloarthropathy. J Rheumatol. 2000;27(9):2256–63.PubMed Minden K, Kiessling U, Listing J, et al. Prognosis of patients with juvenile chronic arthritis and juvenile spondyloarthropathy. J Rheumatol. 2000;27(9):2256–63.PubMed
30.
go back to reference Levinson JE, Wallace CA. Dismantling the pyramid. J Rheumatol Suppl. 1992;33:6–10.PubMed Levinson JE, Wallace CA. Dismantling the pyramid. J Rheumatol Suppl. 1992;33:6–10.PubMed
36.
go back to reference •• Glerup M, Rypdal V, Arnstad ED, et al. Long-term outcomes in juvenile idiopathic arthritis: eighteen years of follow-up in the population-based Nordic juvenile idiopathic arthritis cohort. Arthritis Care Res (Hoboken). 2020;72(4):507–16. https://doi.org/10.1002/acr.23853. This 18-year cohort study examines the longterm outcomes of the early biololgical era.CrossRefPubMed •• Glerup M, Rypdal V, Arnstad ED, et al. Long-term outcomes in juvenile idiopathic arthritis: eighteen years of follow-up in the population-based Nordic juvenile idiopathic arthritis cohort. Arthritis Care Res (Hoboken). 2020;72(4):507–16. https://​doi.​org/​10.​1002/​acr.​23853. This 18-year cohort study examines the longterm outcomes of the early biololgical era.CrossRefPubMed
41.
go back to reference Onel KB, Horton DB, Lovell DJ, et al. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: therapeutic approaches for oligoarthritis, temporomandibular joint arthritis, and systemic juvenile idiopathic arthritis. Arthritis Care Res. 2022;74(4):521–37. https://doi.org/10.1002/acr.24853.CrossRef Onel KB, Horton DB, Lovell DJ, et al. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: therapeutic approaches for oligoarthritis, temporomandibular joint arthritis, and systemic juvenile idiopathic arthritis. Arthritis Care Res. 2022;74(4):521–37. https://​doi.​org/​10.​1002/​acr.​24853.CrossRef
42.
go back to reference Onel KB, Horton DB, Lovell DJ, et al. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: recommendations for nonpharmacologic therapies, medication monitoring, immunizations, and imaging. Arthritis Care Res (Hoboken). 2022;74(4):505–20. https://doi.org/10.1002/acr.24839.CrossRefPubMed Onel KB, Horton DB, Lovell DJ, et al. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: recommendations for nonpharmacologic therapies, medication monitoring, immunizations, and imaging. Arthritis Care Res (Hoboken). 2022;74(4):505–20. https://​doi.​org/​10.​1002/​acr.​24839.CrossRefPubMed
45.
go back to reference Giancane G, Consolaro A, Lanni S, Davì S, Schiappapietra B, Ravelli A. Juvenile Idiopathic Arthritis: diagnosis and treatment. Rheumatol Ther. 2016;3(2):187–207.CrossRefPubMedPubMedCentral Giancane G, Consolaro A, Lanni S, Davì S, Schiappapietra B, Ravelli A. Juvenile Idiopathic Arthritis: diagnosis and treatment. Rheumatol Ther. 2016;3(2):187–207.CrossRefPubMedPubMedCentral
46.
go back to reference Fingerhutova S, Saifridova M, Vranova M, et al. Is there an evidence for the role of multidisciplinary team in the management of active juvenile idiopathic arthritis? Pediatr Rheumatol Online J. 2014;12(Suppl 1):P177–P177.CrossRefPubMedCentral Fingerhutova S, Saifridova M, Vranova M, et al. Is there an evidence for the role of multidisciplinary team in the management of active juvenile idiopathic arthritis? Pediatr Rheumatol Online J. 2014;12(Suppl 1):P177–P177.CrossRefPubMedCentral
68.
go back to reference •• Consolaro A, Giancane G, Alongi A, et al. Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study. Lancet Child Adolesc Health. 2019;3(4):255–63. https://doi.org/10.1016/S2352-4642(19)30027-6. This paper identifies a link between delayed diagnosis and disease damage.CrossRefPubMed •• Consolaro A, Giancane G, Alongi A, et al. Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study. Lancet Child Adolesc Health. 2019;3(4):255–63. https://​doi.​org/​10.​1016/​S2352-4642(19)30027-6. This paper identifies a link between delayed diagnosis and disease damage.CrossRefPubMed
Metadata
Title
Paediatric Rheumatology Fails to Meet Current Benchmarks, a Call for Health Equity for Children Living with Juvenile Idiopathic Arthritis, Using Digital Health Technologies
Authors
Sonia Butler
Dean Sculley
Derek Santos
Xavier Girones
Davinder Singh-Grewal
Andrea Coda
Publication date
11-03-2024
Publisher
Springer US
Published in
Current Rheumatology Reports
Print ISSN: 1523-3774
Electronic ISSN: 1534-6307
DOI
https://doi.org/10.1007/s11926-024-01145-w
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.